RSNN & EMA: Leveraging the value of collaboration – from regulatory science to regulatory innovation

Datum: 17 November 2020

Tijd: 13.30 - 17.30 uur

Locatie: Online

One of the main goals of regulatory science is to inform decision-making with the best evidence, and contribute to a regulatory system that is responsive to societal needs, ensures patient access to efficacious and safe medicines, adapts to scientific innovation and conducive to a fertile R&D ecosystem. In this RSNN workshop we want to explore the key regulatory science questions in the coming years, and especially address how collaborative research can be of most value for regulators, patients, companies, HTA bodies, academia and other stakeholders. Discussions with the audience, representing various backgrounds are a critical element in this respect.

Continue Reading